Free Trial

Entero Therapeutics (ENTO) SEC Filings & 10K Form

$0.42 +0.01 (+2.47%)
(As of 11/21/2024 ET)

Recent Entero Therapeutics SEC Filings

DateFilerForm TypeView
11/13/2024
6:15 AM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
6:00 AM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/21/2024
6:31 AM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/10/2024
4:00 PM
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
Romano Sarah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
4:10 PM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
6:00 AM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/29/2024
3:05 PM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2024
4:00 PM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2024
4:28 PM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
7:00 AM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
7:05 AM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form NT 10-Q
08/14/2024
8:46 PM
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
Ramdeen Timothy R. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/07/2024
4:20 PM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2024
9:54 AM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2024
3:16 PM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
07/23/2024
3:05 PM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2024
7:00 AM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2024
1:33 PM
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
SAPIRSTEIN JAMES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
1:34 PM
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
Romano Sarah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
7:03 AM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/20/2024
3:30 PM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2024
4:23 PM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form PRER14A
06/14/2024
4:15 PM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 424B3
06/12/2024
5:23 PM
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
KHOSLA CHAITAN PHD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
11:15 PM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form EFFECT
06/05/2024
4:15 PM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2024
4:25 PM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/30/2024
4:18 PM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K/A
05/30/2024
4:32 PM
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form DEFA14A
05/16/2024
6:16 AM
First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
4:26 PM
First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/13/2024
4:26 PM
First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
3:59 PM
First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
Form 424B5
05/08/2024
4:16 PM
First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K/A
03/29/2024
3:16 PM
First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/22/2024
4:00 PM
First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2024
3:40 PM
First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2024
3:31 PM
First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
Form DEFA14A
03/15/2024
5:00 PM
First Wave BioPharma, Inc. (Issuer)
First Wave BioPharma, Inc. (Issuer)
Entero Therapeutics (Issuer)
Syage Jack (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/15/2024
5:00 PM
First Wave BioPharma, Inc. (Issuer)
First Wave BioPharma, Inc. (Issuer)
Entero Therapeutics (Issuer)
KHOSLA CHAITAN PHD (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/15/2024
5:05 PM
First Wave BioPharma, Inc. (Issuer)
First Wave BioPharma, Inc. (Issuer)
Entero Therapeutics (Issuer)
KHOSLA CHAITAN PHD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Central Bank Abandons USD (Ad)

You know what doesn't care about elections? Gold. If you want to protect your savings & retirement from our exploding national debt, VOTE FOR GOLD!

Get Your FREE Gold Investor Kit NOW!
03/15/2024
5:05 PM
First Wave BioPharma, Inc. (Issuer)
First Wave BioPharma, Inc. (Issuer)
Entero Therapeutics (Issuer)
Syage Jack (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2024
5:10 AM
First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
Form DEFA14A
03/14/2024
5:09 AM
First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2024
4:29 PM
First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
Form 424B5
02/14/2024
1:45 PM
ARMISTICE CAPITAL, LLC (Filed by)
First Wave BioPharma, Inc. (Subject)
First Wave BioPharma, Inc. (Subject)
Entero Therapeutics (Subject)
Form SC 13G/A
01/17/2024
11:15 PM
First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
Form EFFECT
01/08/2024
4:14 PM
First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/04/2024
4:12 PM
BORKOWSKI EDWARD (Reporting)
First Wave BioPharma, Inc. (Issuer)
First Wave BioPharma, Inc. (Issuer)
Entero Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
4:13 PM
Coelho Mary Theresa (Reporting)
First Wave BioPharma, Inc. (Issuer)
First Wave BioPharma, Inc. (Issuer)
Entero Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
4:13 PM
First Wave BioPharma, Inc. (Issuer)
First Wave BioPharma, Inc. (Issuer)
Entero Therapeutics (Issuer)
Riddell Alastair (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
4:14 PM
CASAMENTO CHARLES J (Reporting)
First Wave BioPharma, Inc. (Issuer)
First Wave BioPharma, Inc. (Issuer)
Entero Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
7:22 AM
First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2024
6:54 PM
First Wave BioPharma, Inc. (Issuer)
First Wave BioPharma, Inc. (Issuer)
Entero Therapeutics (Issuer)
Romano Sarah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
6:55 PM
First Wave BioPharma, Inc. (Issuer)
First Wave BioPharma, Inc. (Issuer)
Entero Therapeutics (Issuer)
SAPIRSTEIN JAMES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2023
11:21 AM
First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
Form RW
12/27/2023
4:23 PM
First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2023
7:04 AM
First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
Form S-1/A
12/27/2023
5:15 AM
First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2023
6:00 AM
First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/15/2023
8:48 PM
First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
Form S-1/A
12/14/2023
8:15 AM
First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ENTO) was last updated on 11/22/2024 by MarketBeat.com Staff
From Our Partners